Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otrivine for nasal congestion due to the common cold
ISRCTN74996920Phase 4Completed
- Sponsor
- The Virtual Clinical Trials Centre
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of xylometazoline in nasopharyngitis, sponsored by The Virtual Clinical Trials Centre. Primary endpoints: WURSS-21 total score over time, WURSS-21 total symptom domain score over time and 2 more. Started Nov 2022; status: completed.
02
Drugs
xylometazoline
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ISRCTN74996920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN74996920.